Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 8
Submit an article Journal homepage
2,304
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine

Yoshikazu Nagasea Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanORCID Iconhttps://orcid.org/0000-0003-0994-1600View further author information
ORCID Icon,
Yutaka Uedaa Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanCorrespondence[email protected]
View further author information
,
Hazuki Abea Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Asami Yagia Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Masaaki Sawadaa Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Satoshi Nakagawaa Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Kosuke Hiramatsua Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Tomomi Egawa-Takatab Department of Obstetrics and Gynecology, Osaka Police Hospital, Osaka, JapanORCID Iconhttps://orcid.org/0000-0003-3088-1091View further author information
ORCID Icon,
Shinya Matsuzakia Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanORCID Iconhttps://orcid.org/0000-0001-5725-9994View further author information
ORCID Icon,
Eiji Kobayashia Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
,
Toshihiro Kimuraa Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
&
Tadashi Kimuraa Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, JapanView further author information
 show all
Pages 1808-1813 | Received 10 Oct 2019, Accepted 01 Jan 2020, Published online: 16 Jan 2020

References

  • Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928–43. doi:10.1056/NEJMoa061760.
  • Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14. doi:10.1016/S0140-6736(09)61248-4.
  • Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis. 2011;11:13. doi:10.1186/1471-2334-11-13.
  • Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan’s failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol. 2015;212:405–06. doi:10.1016/j.ajog.2014.11.037.
  • Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385:2571. doi:10.1016/S0140-6736(15)61152-7.
  • Japanese Immunization Act (Act No. 68 of June 30, 1948), Article 5 (1). [accessed 2019 Nov 30]. https://www.mhlw.go.jp/web/t_doc?dataId=79015000&dataType=0&pageNo=1.
  • The Ministry of Health, Labour and Welfare. 2013 Jun 14. [accessed 2019 Nov 30]. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/pdf/kankoku_h25_6_01.pdf.
  • Bratic JS, Seyferth ER, Bocchini JA Jr. Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance. Curr Opin Pediatr. 2016;28:407–12. doi:10.1097/MOP.0000000000000353.
  • Egawa-Takata T, Ueda Y, Morimoto A, Yoshino K, Kimura T, Nishikawa N, Sekine M, Horikoshi Y, Takagi T, Enomoto T. Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination. J Obstet Gynaecol Res. 2015;41:1965–71. doi:10.1111/jog.12822.
  • Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Matsuzaki S, Kobayashi E, Yoshino K, Sekine M, Enomoto T, Kimura T, et al. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan. Int J Clin Oncol. 2016;21:53–58. doi:10.1007/s10147-015-0869-5.
  • Sawada M, Ueda Y, Yagi A, Morimoto A, Nakae R, Kakubari R, Abe H, Egawa-Takata T, Iwamiya T, Matsuzaki S, et al. HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine. Int J Clin Oncol. 2018;23:121–25. doi:10.1007/s10147-017-1188-9.
  • The statement of Global Advisory Committee on Vaccine Safety. 2015 Dec 2–3. [accessed 2019 Aug 15]. https://www.who.int/vaccine_safety/committee/reports/wer9103.pdf.
  • The report of the Vaccine Adverse Reaction Review Committee (VARRC). [accessed 2019 Aug 15]. https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000147016.pdf.
  • Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, Paavonen J, Pukkala E, Lehtinen M. Vaccination protects against invasive HPV-associated cancers. Int J Cancer. 2018;142:2186–87. doi:10.1002/ijc.31231.
  • Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res. 2018;5:96–103. doi:10.1016/j.pvr.2018.02.002.
  • The leaflet on HPV vaccines published by the Ministry of Health, Labour and Welfare. 2018 Jan [accessed 2019 Aug 15]. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/dl/hpv180118-info01.pdf.
  • Yagi A, Ueda Y, Kakuda M, Tanaka Y, Ikeda S, Matsuzaki S, Kobayashi E, Morishima T, Miyashiro I, Fukui K, et al. Epidemiologic and clinical analysis of cervical cancer using data from the population-based Osaka cancer registry. Cancer Res. 2019;79:1252–59. doi:10.1158/0008-5472.CAN-18-3109.
  • Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T. Outcomes for girls without HPV vaccination in Japan. Lancet Oncol. 2016;17:868–69. doi:10.1016/S1470-2045(16)00147-9.
  • Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, et al. Realistic fear of cervical cancer risk in Japan depending on birth year. Hum Vaccin Immunother. 2017;13:1700–04. doi:10.1080/21645515.2017.129219.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.